Literature DB >> 9074501

Molecular cloning and characterization of Borrelia burgdorferi rpoB.

M Alekshun1, M Kashlev, I Schwartz.   

Abstract

Borrelia burgdorferi rpoB, the gene encoding the beta-subunit of RNA polymerase, has been cloned and sequenced. The full-length gene encodes a protein of 1154 amino acids with a calculated molecular mass of 129.8 kDa. The amino-acid sequence is 49% identical to the corresponding protein from Escherichia coli. B. burgdorferi rpoB is a component of a gene cluster, which includes rplJ, rplL and rpoC. A temperature-sensitive E. coli rpoB mutant could be complemented by introduction of the B. burgdorferi gene, indicating that the B. burgdorferi rpoB is expressed in E. coli and the beta-subunit can be assembled into functional holoenzyme. The wild-type amino-acid sequence of the B. burgdorferi beta-subunit is consistent with those of spontaneously arising rifampicin-resistant mutants of E. coli and Mycobacterium tuberculosis at certain critical residues. This suggests that the natural resistance of B. burgdorferi to rifampicin may be due to the primary amino-acid sequence of its beta-subunit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074501     DOI: 10.1016/s0378-1119(96)00714-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Natural rifampin resistance in Treponema spp. correlates with presence of N531 in RpoB rif cluster i.

Authors:  L V Stamm; H L Bergen; K A Shangraw
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  rpoB gene analysis as a novel strategy for identification of spirochetes from the genera Borrelia, Treponema, and Leptospira.

Authors:  P Renesto; K Lorvellec-Guillon; M Drancourt; D Raoult
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes.

Authors:  Peter Spanogiannopoulos; Maulik Thaker; Kalinka Koteva; Nicholas Waglechner; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

4.  Differentiation of Borrelia burgdorferi sensu lato on the basis of RNA polymerase gene (rpoB) sequences.

Authors:  S H Lee; B J Kim; J H Kim; K H Park; S J Kim; Y H Kook
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.

Authors:  Vadim Molodtsov; Nathan T Scharf; Maxwell A Stefan; George A Garcia; Katsuhiko S Murakami
Journal:  Mol Microbiol       Date:  2017-01-10       Impact factor: 3.501

6.  Transcript decay mediated by RNase III in Borrelia burgdorferi.

Authors:  Santina Snow; Emily Bacon; Jennifer Bergeron; David Katzman; Amelia Wilhelm; Owen Lewis; Deepsing Syangtan; Andrew Calkins; Linda Archambault; Melissa L Anacker; Paula Jean Schlax
Journal:  Biochem Biophys Res Commun       Date:  2020-07-01       Impact factor: 3.575

7.  Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB).

Authors:  B J Kim; S H Lee; M A Lyu; S J Kim; G H Bai; G T Chae; E C Kim; C Y Cha; Y H Kook
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Analysis of core housekeeping and virulence genes reveals cryptic lineages of Clostridium perfringens that are associated with distinct disease presentations.

Authors:  Alejandro P Rooney; James L Swezey; Robert Friedman; David W Hecht; Carol W Maddox
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

9.  Functional properties of Borrelia burgdorferi recA.

Authors:  Dionysios Liveris; Vishwaroop Mulay; Ira Schwartz
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 10.  Global challenge of antibiotic-resistant Treponema pallidum.

Authors:  Lola V Stamm
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.